Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble CoInhibitory and CoStimulatory Immune Checkpoint Molecules

Bernardo L. RapoportHelen C. SteelNomsa HlatshwayoAnnette J. TheronE et alSimon Nayler2023-10-122023-10-12WOS1664-3224https://hdl.handle.net/10539/36715Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble CoInhibitory and CoStimulatory Immune Checkpoint Molecules